{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-115857","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2024-04-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.160486+00:00","generated_at":"2026-06-03T06:59:36.548829+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"HCA Q1 revenue up 11% to $17.34B, EPS $5.93; reaffirms FY guidance","bullets":["Revenue $17.339B (+11.2% YoY); net income $1.591B ($5.93 diluted EPS) vs $1.363B ($4.85).","Adjusted EBITDA $3.353B; same facility admissions +6.2%, equivalent admissions +5.2%.","Cash from operations $2.469B; repurchased 3.894M shares for $1.180B; $5.595B remaining.","Board declared $0.66/share dividend, payable June 28 to holders of record June 14.","Reaffirmed 2024 guidance; includes $201M gain on sale of California hospital."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-115857","json":"https://secwatch.observer/filing/0001193125-24-115857.json","markdown":"https://secwatch.observer/filing/0001193125-24-115857.md","text":"https://secwatch.observer/filing/0001193125-24-115857.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312524115857/0001193125-24-115857-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312524115857/d799245d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T06:59:36.548829+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"85f90cead3c7967d1f294ae3a8fed2402bf8e463","claim":"HCA Healthcare, Inc. reported the first quarter ended March 31, 2024 results: revenue $17.339 billion, net income $1.591 billion, EPS $5.93 per diluted share. Guidance reaffirmed.","evidence_excerpt":"HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare 1Q 2024 to 1Q 2023 unless otherwise noted): ● Revenues totaled $17.339 billion ● Net income attributable to HCA Healthcare, Inc. totaled $1.591 billion, or $5.93 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312524115857/0001193125-24-115857-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Revenue","value":"$17.339 billion"},{"label":"Net income","value":"$1.591 billion"},{"label":"EPS","value":"$5.93 per diluted share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}